| Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis G Li, F Jin, J Du, Q He, B Yang, P Luo Toxicology and applied pharmacology 366, 10-16, 2019 | 62 | 2019 |
| NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth X Zha, Z Hu, S Ji, F Jin, K Jiang, C Li, P Zhao, Z Tu, X Chen, L Di, H Zhou, ... Cancer letters 359 (1), 97-106, 2015 | 57 | 2015 |
| Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory F Jin, X Chen, H Yan, Z Xu, B Yang, P Luo, Q He European Journal of Pharmacology 874, 173026, 2020 | 37 | 2020 |
| Bisdemethoxycurcumin protects against renal fibrosis via activation of fibroblast apoptosis F Jin, Y Jin, J Du, L Jiang, Y Zhang, Z Zhao, B Yang, P Luo, Q He European Journal of Pharmacology 847, 26-31, 2019 | 30 | 2019 |
| Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex F Jin, K Jiang, S Ji, L Wang, Z Ni, F Huang, C Li, R Chen, H Zhang, Z Hu, ... Human Molecular Genetics 26 (2), 407-419, 2017 | 27 | 2017 |
| AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development X Wan, M Zhou, F Huang, N Zhao, X Chen, Y Wu, W Zhu, Z Ni, F Jin, ... Cell Death & Disease 12 (2), 172, 2021 | 20 | 2021 |
| Combined targeting of mTOR and Akt using rapamycin and MK-2206 in the treatment of tuberous sclerosis complex S Ji, W Lin, L Wang, Z Ni, F Jin, X Zha, G Fei Journal of Cancer 8 (4), 555, 2017 | 20 | 2017 |
| mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency H Li, F Jin, K Jiang, S Ji, L Wang, Z Ni, X Chen, Z Hu, H Zhang, Y Liu, ... Oncotarget 7 (19), 28435, 2016 | 17 | 2016 |
| KLF5-mediated COX2 upregulation contributes to tumorigenesis driven by PTEN deficiency L Zhang, Y Wu, J Wu, M Zhou, D Li, X Wan, F Jin, Y Wang, W Lin, X Zha, ... Cellular Signalling 75, 109767, 2020 | 7 | 2020 |
| Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development L Wang, Z Ni, Y Liu, S Ji, F Jin, K Jiang, J Ma, C Ren, H Zhang, Z Hu, ... Oncotarget 8 (33), 54858, 2017 | 6 | 2017 |
